Piramal Pharma consolidated net profit rises 350.00% in the September 2024 quarter

Net profit of Piramal Pharma rose 350.00% to Rs 22.59 crore in the quarter ended September 2024 as against Rs 5.02 crore during the previous quarter ended September 2023. Sales rose 17.28% to Rs 2241.75 crore in the quarter ended September 2024 as against Rs 1911.38 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	2241.75	1911.38	17
OPM %	15.24	13.90	-
PBDT	312.34	224.07	39
PBT	120.12	39.56	204
NP	22.59	5.02	350